Thioredoxin pseudogene 1 (TXNP1)

Thioredoxin pseudogene 1 (TXNP1) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to the thioredoxin gene but generally considered non-functional. It does not encode a functional protein, is not involved in cellular signaling or enzymatic activities like active thioredoxin family members, and is not considered a therapeutic target. No aliases, molecular functions, or interactions with drugs are known. Its designation as a pseudogene may cause confusion, as it resembles therapeutic protein targets such as thioredoxin (TRX) and thioredoxin interacting protein (TXNIP), both of which are involved in redox regulation and recognized roles in disease biology[1][2][5][6][7]. Important context: TXNP1 is not the same as "Thioredoxin 1" (TXN or TRX1) or "Thioredoxin interacting protein" (TXNIP), both of which are established biological targets extensively involved in redox signaling, apoptosis, metabolism, and disease, and are sometimes therapeutically relevant[1][2][3][5][6][7]. No current evidence suggests that TXNP1 is a functional protein or a drug target. If you intended to refer to Thioredoxin 1 (TXN/TRX1) or Thioredoxin interacting protein (TXNIP), please clarify, as they are distinct therapeutic targets with biological roles and disease associations.